IDIS
IDIS is a public Galician biomedical research foundation coordinating 60+ research groups across seven disease areas, delivering translational research, training, technology transfer, and spin-offs, funded primarily through competitive grants and institutional partnerships.
- Company typePrivate
- Founded2020
- HeadquartersSantiago De Compostela, Spain
- Headcount11–50
- GTM typeB2B
- OfferingServices
What IDIS does
IDIS is a public biomedical research foundation (Fundación Pública Galega) headquartered within the Hospital Clínico Universitario de Santiago de Compostela complex in Galicia, Spain. It coordinates more than 60 research groups across seven strategic areas — oncology, genetics and systems biology, endocrinology/nutrition/metabolism, neurosciences, platforms and methodology, cardiovascular, and infectology/inflammation/vaccines — and provides translational research services, training programs, and shared technological platforms including a biobank and clinical research management systems. The institute is governed through FIDIS, its management foundation, under María Gómez-Reino, with scientific direction held by Mª Luz Couce Pico and area leadership including Rafael López López (oncology), Ángel Carracedo Álvarez (genetics), and Federico Martinón Torres (infectology).
The institute operates through a multi-channel engagement model encompassing competitive grant pursuit, philanthropic fundraising via FIDIS, technology transfer, and spin-off creation. Its core service offerings include a Technology Portfolio (Oferta Tecnológica), Software and Apps, Licensed Technologies, spin-off companies (Nasasbiotech with the M-Trap tumor cell capture device; DIVERSA Technologies), and the Código Rojo AI-medical-education platform. Revenue derives primarily from competitive research grants (ISCIII, European Commission, private foundations) and competitive staff contracts — 2026 fund attraction exceeded 50.9 million euros — with no direct product commercialization. Customers are not commercial buyers but rather institutional partners: Hospital Clínico Universitario de Santiago de Compostela (primary clinical host), Servizo Galego de Saúde (SERGAS), Universidade de Santiago de Compostela (USC), Instituto de Salud Carlos III (ISCIII), and ACIS, plus alignment with the European Open Science Cloud.
The go-to-market motion is community-led: IDIS engages the scientific community, healthcare professionals, and broader society through collaborative research, training, scientific seminars (IDIS Wednesdays), public outreach via the UCC+i unit, and multi-channel digital presence including a multilingual website and active profiles on LinkedIn, X, Facebook, Instagram, and YouTube. Distribution of research outputs occurs through open-access scientific publication, spin-off commercialization, and licensing of developed technologies. The institute holds HR Excellence in Research certification from the European Commission (since 2020) and ISCIII reaccreditation, signaling compliance with recognized European research quality standards.
IDIS firmographics
Firmographics- Name
- IDIS
- Legal name
- FUNDACIÓN PÚBLICA GALEGA INSTITUTO DE INVESTIGACIÓN SANITARIA DE SANTIAGO DE COMPOSTELA
- Website
- https://idisantiago.es
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- IDIS is a public Galician biomedical research foundation coordinating 60+ research groups across seven disease areas, delivering translational research, training, technology transfer, and spin-offs, funded primarily through competitive grants and institutional partnerships.
- Ownership category
- akta.pro rank
IDIS industry classification
Industry- Product category
- Biomedical Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
- akta.pro secondary industries
- Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG), Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)
Keywords
Where IDIS is headquartered
LocationHeadquarters
- HQ city
- Santiago De Compostela
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
IDIS business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Others
Revenue model
- Competitive Research Grants: Funding from national and international competitive calls including ISCIII, European Commission, and private foundations for research projects
- Donations and Philanthropy: Individual and organizational donations managed through FIDIS foundation with tax deduction benefits under Spanish Law 49/2002
- Competitive Staff Contracts: Nearly 10 million euros from competitive staff contracts supporting research personnel
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
IDIS product offering
Product offeringCore offering
IDIS is a public health research institute that conducts translational biomedical research across seven strategic areas—oncology, genetics and genomics, cardiovascular, neurosciences, endocrinology, infectious diseases, and methodological/platform research—coordinating more than 60 research groups affiliated with Hospital Clínico Universitario de Santiago and the Universidade de Santiago de Compostela. Beyond performing research, it operates shared core platforms (biobank, clinical trials management) and runs a technology-transfer program that licenses out medical devices, software applications, and spin-off companies developed from its research pipeline.
Product overview
IDIS is a health research institute that functions as a platform for translational biomedical research, offering technology transfer services, software applications, licensed technologies, and spin-off companies. The organization operates through multiple interconnected services: technology offerings (Oferta tecnológica) for commercialization, software and apps development, licensed technologies, and spin-off companies. Key offerings include research platforms, diagnostic devices like M-Trap for tumor cell capture, and the Código Rojo medical education platform. The institute provides research infrastructure, laboratory management, clinical research services, and training programs, functioning as a comprehensive research ecosystem rather than a single unified product.
Differentiator
Problem solved
Functional benefit
Companies that use IDIS
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
IDIS technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature3 records
IDIS partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and strategic.
- Servizo Galego de Saúde (SERGAS)coreCore institutional partnership providing clinical research infrastructure through Hospital Clínico Universitario de Santiago de Compostela. SERGAS is the Galician Health Service that enables translation of research into clinical practice.
- Universidade de Santiago de Compostela (USC)coreAcademic partner providing research excellence and training through university faculty and research groups integrated into IDIS.
- Instituto de Salud Carlos III (ISCIII)coreNational health research institute providing accreditation and funding for health research institutes across Spain. IDIS received reaccreditation from ISCIII.
- Axencia de Coñecemento en Saúde (ACIS)coreGalician Health Knowledge Agency that coordinates health innovation and research programs including European projects like TITTAN.
- European Open Science Cloud (EOSC)strategicIDIS open science policy aligns with EOSC principles for Findable, Accessible, Interoperable and Reusable (FAIR) data publication in recognized open repositories.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
IDIS competitors and assessment
Company assessmentDirect peers
- IBIMA - Instituto de Investigación Biomédica de Málaga: ISCIII-accredited Spanish health research institute integrating hospital and university research across multiple therapeutic areas; structurally and operationally comparable to IDIS in governance, funding model, and translational focus.
- IBSAL - Instituto de Investigación Biomédica de Salamanca: ISCIII-accredited biomedical research institute in Salamanca covering oncology, cardiovascular, neurosciences and other areas with a similar hospital-university foundation model to IDIS.
- IDIVAL - Instituto de Investigación Sanitaria Valdecilla: ISCIII-accredited health research institute linked to Hospital Universitario Marqués de Valdecilla, with comparable translational research scope and competitive grant funding profile to IDIS.
- IIS La Fe - Instituto de Investigación Sanitaria La Fe: Large ISCIII-accredited Spanish health research institute based at Hospital La Fe in Valencia, operating multiple research areas and clinical platforms analogous to IDIS, but at a larger scale.
- IMIM - Institut Hospital del Mar d'Investigacions Mèdiques: Barcelona-based biomedical research institute linked to Hospital del Mar; ISCIII-accredited and operating a comparable translational research, clinical trials, and competitive-grant funding model.
Broad incumbents
- IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer: Larger, internationally prominent Barcelona-based biomedical research institute affiliated with Hospital Clínic; operates the same translational research and clinical trials model as IDIS but with significantly greater funding scale and global visibility.
- VHIO - Vall d'Hebron Institut d'Oncologia: Leading oncology-focused research center at Vall d'Hebron Barcelona Hospital Campus; overlaps with IDIS' oncology area but operates at larger scale and with deeper industry partnerships.
- CNIO - Centro Nacional de Investigaciones Oncológicas: Spain's national cancer research centre, a much larger publicly funded institution with overlapping oncology research scope, broader international profile, and substantial competitive grant capture.
- IRB Barcelona - Institute for Research in Biomedicine: Well-established Barcelona-based biomedical research centre with comparable multi-area basic and translational research structure; competes for overlapping EU and competitive grants and scientific talent.
Regional players
- IIS Aragón - Instituto de Investigación Sanitaria Aragón: ISCIII-accredited regional health research institute in Aragón with a similar hospital-university foundation structure, but operating in a different Spanish region without direct overlap in catchment area.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
IDIS social profiles
Digital presenceIDIS financial estimates
Financial estimateRevenue estimate
Valuation estimate
IDIS leadership team
Management profileNumber of profiles
IDIS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IDIS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IDIS
What does IDIS do?
IDIS is a public health research institute that conducts translational biomedical research across seven strategic areas—oncology, genetics and genomics, cardiovascular, neurosciences, endocrinology, infectious diseases, and methodological/platform research—coordinating more than 60 research groups affiliated with Hospital Clínico Universitario de Santiago and the Universidade de Santiago de Compostela. Beyond performing research, it operates shared core platforms (biobank, clinical trials management) and runs a technology-transfer program that licenses out medical devices, software applications, and spin-off companies developed from its research pipeline.
Is IDIS a public or private company?
IDIS is a private company. It is classified as state government owned and is currently operating.
When was IDIS founded?
IDIS was founded in 2020. It employs 11 to 50 people.
Where is IDIS based?
IDIS is headquartered in Santiago De Compostela, Spain, in the Europe region.
How does IDIS make money?
Three revenue lines are on record. Competitive Research Grants are the primary driver. The others are donations and Philanthropy and competitive Staff Contracts.
Who are IDIS's main competitors?
Direct peers on record are IBIMA - Instituto de Investigación Biomédica de Málaga, IBSAL - Instituto de Investigación Biomédica de Salamanca, IDIVAL - Instituto de Investigación Sanitaria Valdecilla, IIS La Fe - Instituto de Investigación Sanitaria La Fe and IMIM - Institut Hospital del Mar d'Investigacions Mèdiques. Broad incumbents are IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer, VHIO - Vall d'Hebron Institut d'Oncologia, CNIO - Centro Nacional de Investigaciones Oncológicas and IRB Barcelona - Institute for Research in Biomedicine. IIS Aragón - Instituto de Investigación Sanitaria Aragón is listed as a regional player.
Does IDIS have an API?
No public API is recorded for IDIS.
What industry is IDIS in?
IDIS's product category is Biomedical Research Services. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF), with a secondary code of HLAGAOAG, Medical Affairs, Scientific Communications & HEOR FSP. Its NAICS code is 54171 and its SIC code is 8731.